Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Technology Potential, Competitive Market Share & Forecast, 2019 - 2025
Direct-to-Consumer (DTC) Genetic Testing Market will exceed USD 2.5 billion by 2025; as per a new research report.
Rising incidences of genetic disorder will positively impact DTC genetic testing market growth in forthcoming years. Significant increase in prevalence of genetic diseases such as sickle cell anemia, haemophilia, thalassemia, Tay Sachs disease, cystic fibrosis and Huntington's disease will surge demand for DTC genetic testing kits. According to WHO, about 72,000 people in the U.S. alone are affected from sickle cell anemia annually. Demand for direct to consumer testing kits has increased as it enables customers to access detailed information pertaining to genetic variation associated with these diseases.
Growing income level globally will boost the demand for direct to consumer genetic testing kits thereby, escalating industry growth. Increase in income level subsequently elevates healthcare expenditures that proves beneficial for industry growth. According to CDC, 2017 witnessed drastic increase in number of people opting direct to consumer genetic testing. This rise in the customer base for DTC genetic tests can be attributed to increase in income level, awareness and reduced prices. However, defects in DTC genetic testing kits may hamper business growth to certain extent.
Ancestry and relationship testing segment will experience around 13% growth in the coming years as these tests give detailed and accurate information regarding ethnic background of an individual. Moreover, recently developed ancestry DTC tests bridges gap between health-related genetic testing and ancestry genetic testing. Availability of such ancestry DTC tests will spur the segmental growth in coming years.
Targeted analysis segment accounted for over 37% revenue share in 2018 owing to its increasing demand in genome analysis. Several benefits of targeted analysis include specificity, scalability and cost-effectiveness. Since, this technology has numerous advantages as compared to the other technologies such as Single Nucleotide Polymorphism (SNP) its adoption will remain high throughout the forecast period.
North America DTC genetic testing market will experience around 14% growth throughout the analysis period owing to favorable regulatory scenario. Regulatory bodies such as FDA frame laws that ensures availability of superior quality DTC genetic tests. Moreover, growing inclination of people towards the personalized medicines in the U.S. as well as Canada further boosts the regional growth.
Prominent industry players operational in direct to consumer genetic testing market include 23andMe, Full Genomes, Ancestry, Color, Helix, Karmagenes, MapMyGenome, Family Tree DNA, EasyDNA, Helix, Identigene, Genesis HealthCare, Karmagenes, MyHeritage, Living DNA and Pathway Genomics. Key industry players adopt strategic initiatives such as new product launch, collaborations and geographic expansions that enables them to sustain market competition. For instance, in November 2018, Ancestry.com developed Ancestry DNA test that provides detailed genetic information. This strategy will help company to enhance its product portfolio.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook